Found: 77
Select item for more details and to access through your institution.
Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 11, p. 1233, doi. 10.3390/jpm11111233
- By:
- Publication type:
- Article
Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31199-2
- By:
- Publication type:
- Article
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 3, p. 366, doi. 10.1016/j.clgc.2023.02.010
- By:
- Publication type:
- Article
Comprehensive genomic profiling of treatment resistant metastatic castrate sensitive prostate cancer reveals high frequency of potential therapeutic targets.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 3, p. 278, doi. 10.1016/j.clgc.2022.02.004
- By:
- Publication type:
- Article
Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 3, p. 210, doi. 10.1016/j.clgc.2021.12.003
- By:
- Publication type:
- Article
Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 6, p. 521, doi. 10.1016/j.clgc.2021.05.004
- By:
- Publication type:
- Article
Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 4, p. 354, doi. 10.1016/j.clgc.2021.03.006
- By:
- Publication type:
- Article
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma.
- Published in:
- Cancer Reports, 2023, v. 6, n. 3, p. 1, doi. 10.1002/cnr2.1763
- By:
- Publication type:
- Article
Out‐of‐pocket costs associated with head and neck cancer treatment.
- Published in:
- Cancer Reports, 2022, v. 5, n. 7, p. 1, doi. 10.1002/cnr2.1528
- By:
- Publication type:
- Article
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25432-7
- By:
- Publication type:
- Article
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults.
- Published in:
- Current Oncology, 2021, v. 28, n. 1, p. 523, doi. 10.3390/curroncol28010053
- By:
- Publication type:
- Article
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer.
- Published in:
- Current Oncology, 2021, v. 28, n. 1, p. 107, doi. 10.3390/curroncol28010014
- By:
- Publication type:
- Article
Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 2, p. e222, doi. 10.1111/ajco.12167
- By:
- Publication type:
- Article
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 3, p. 241, doi. 10.1007/s10637-024-01428-0
- By:
- Publication type:
- Article
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 1, p. 145, doi. 10.1007/s10637-023-01410-2
- By:
- Publication type:
- Article
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-023-03623-z
- By:
- Publication type:
- Article
Applications of Circulating Tumor DNA in a Cohort of Phase I Solid Tumor Patients Treated With Immunotherapy.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 3, p. 1, doi. 10.1093/jncics/pkaa122
- By:
- Publication type:
- Article
Systematic Review and STARD Scoring of Renal Cell Carcinoma Circulating Diagnostic Biomarker Manuscripts.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 5, p. 1, doi. 10.1093/jncics/pkaa050
- By:
- Publication type:
- Article
Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 4, p. N.PAG, doi. 10.1093/jncics/pkz071
- By:
- Publication type:
- Article
Structure and Optimization of Checkpoint Inhibitors.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 38, doi. 10.3390/cancers12010038
- By:
- Publication type:
- Article
Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study.
- Published in:
- PLoS ONE, 2021, v. 16, n. 12, p. 1, doi. 10.1371/journal.pone.0259272
- By:
- Publication type:
- Article
Pre‐ and Post‐Radiotherapy Radiologic Nodal Features and Oropharyngeal Cancer Outcomes.
- Published in:
- Laryngoscope, 2021, v. 131, n. 4, p. E1162, doi. 10.1002/lary.29045
- By:
- Publication type:
- Article
Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS‐001 clinical trial.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 20, p. 20299, doi. 10.1002/cam4.6589
- By:
- Publication type:
- Article
Semen and serum platinum levels in cisplatin‐treated survivors of germ cell cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 3, p. 728, doi. 10.1002/cam4.4480
- By:
- Publication type:
- Article
Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration‐resistant prostate cancer treated with Radium‐223.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 17, p. 5775, doi. 10.1002/cam4.4125
- By:
- Publication type:
- Article
Quality of patient‐reported outcomes in oncology clinical trials using immune checkpoint inhibitors: A systematic review.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 15, p. 5031, doi. 10.1002/cam4.4086
- By:
- Publication type:
- Article
Cancer patients' experiences with immune checkpoint modulators: A qualitative study.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 9, p. 3015, doi. 10.1002/cam4.2940
- By:
- Publication type:
- Article
Clinical application of high-throughput genomic technologies for treatment selection in breast cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscripts.
- Published in:
- PLoS ONE, 2019, v. 14, n. 10, p. 1, doi. 10.1371/journal.pone.0222359
- By:
- Publication type:
- Article
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 334, doi. 10.1016/j.clcc.2021.07.004
- By:
- Publication type:
- Article
Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial.
- Published in:
- JAMA Otolaryngology-Head & Neck Surgery, 2024, v. 150, n. 6, p. 463, doi. 10.1001/jamaoto.2024.0423
- By:
- Publication type:
- Article
Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours.
- Published in:
- BJU International, 2018, v. 122, n. 5, p. 814, doi. 10.1111/bju.14372
- By:
- Publication type:
- Article
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 12, p. 1936, doi. 10.1038/s41416-024-02701-y
- By:
- Publication type:
- Article
A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 4, p. 612, doi. 10.1038/s41416-023-02307-w
- By:
- Publication type:
- Article
The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 10, p. 1888, doi. 10.1038/s41416-023-02166-5
- By:
- Publication type:
- Article
Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Tumour heterogeneity in the clinic.
- Published in:
- Nature, 2013, v. 501, n. 7467, p. 355, doi. 10.1038/nature12627
- By:
- Publication type:
- Article
The Survival Outcomes of the Metastatic Nonclear Cell Renal Cell Carcinoma in the Immunotherapy Era: Princess Margaret Cancer Centre Experience.
- Published in:
- Journal of Kidney Cancer & VHL, 2024, v. 11, n. 1, p. 41, doi. 10.15586/jkcvhl.v11i1.307
- By:
- Publication type:
- Article
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT).
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02851-6
- By:
- Publication type:
- Article
Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2625, doi. 10.1111/cts.13387
- By:
- Publication type:
- Article
Mapping the EORTC QLQ‐C30 and QLQ‐H&N35, onto EQ‐5D‐5L and HUI‐3 indices in patients with head and neck cancer.
- Published in:
- Head & Neck, 2020, v. 42, n. 9, p. 2277, doi. 10.1002/hed.26181
- By:
- Publication type:
- Article
Mapping the University of Washington Quality of life questionnaire onto EQ‐5D and HUI‐3 indices in patients with head and neck cancer.
- Published in:
- Head & Neck, 2020, v. 42, n. 3, p. 513, doi. 10.1002/hed.26031
- By:
- Publication type:
- Article
A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 3, p. 271, doi. 10.1007/s11523-022-00884-z
- By:
- Publication type:
- Article
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 4, p. 461, doi. 10.1007/s11523-021-00813-6
- By:
- Publication type:
- Article
Determinants of the recommended phase 2 dose of molecular targeted agents.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Real-Word Experience of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis).
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 1, p. 21, doi. 10.3233/KCA-210110
- By:
- Publication type:
- Article
Real‐World Assessment of Clinical Outcomes Among First‐Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 422, doi. 10.1634/theoncologist.2019-0605
- By:
- Publication type:
- Article